ArticleCancers2021
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer.
Abstract readConsensus Statement
In one paragraph
Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Insights on postneoadjuvant treatment among patients with triple-negative breast cancer and residual disease after neoadjuvant therapy: can expert consensus help to interpret the current evidence?British journal of cancer · 2026Article
- Endocrine Disruptors and Breast Cancer: A Comprehensive Review.Biomedicines · 2025Review
- Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment.Molecules (Basel, Switzerland) · 2023Review
- Revealing the Potential Markers of N(4)-Acetylcytidine through acRIP-seq in Triple-Negative Breast Cancer.Genes · 2022Article
- Efficacy of different neoadjuvant treatment regimens in BRCA-mutated triple negative breast cancer: a systematic review and meta-analysis.Hereditary cancer in clinical practice · 2022Review
- In-Silico Drug Toxicity and Interaction Prediction for Plant Complexes Based on Virtual Screening and Text Mining.International journal of molecular sciences · 2022Article
- Review
- Ferroptosis and triple-negative breast cancer: Potential therapeutic targets.Frontiers in oncology · 2022Article
- Clinico-pathological relationship between androgen receptor and tumour infiltrating lymphocytes in triple negative breast cancer.Ecancermedicalscience · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
39 authors.
Hesham ElghazalyClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.ORCID 0000-0002-9327-286X
Hope S RugoDepartment of Medicine, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA 94158, USA.
Hamdy A AzimClinical Oncology Department, Kasr Alainy School of Medicine, Cairo University, Giza 12613, Egypt.
Sandra M SwainLombardi Comprehensive Cancer Center, Georgetown University Medical Center, MedStar Health, Washington, DC 20007, USA.
Banu ArunDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Matti AaproBreast Center, Clinique de Genolier, 1272 Genolier, Switzerland.
Edith A PerezDepartment of Hematology & Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.
Benjamin O AndersonBreast Health Global Initiative, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98195, USA.
Frederique Penault-LlorcaDepartment of Pathology, Clermont Auvergne University, INSERM U1240 "Molecular Imaging and Theranostic Strategies", Center Jean Perrin, Montalembert, 63000 Clermont-Ferrand, France.
Pierfranco ConteDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Istituto Oncologico Veneto IOV IRCCS, 35128 Padova, Italy.ORCID 0000-0002-5210-5344
Nagi S El SaghirDepartment of Internal Medicine, Division of Hematology Oncology, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon.ORCID 0000-0001-9612-4224
Cheng-Har YipSubang Jaya Medical Centre, Kuala Lumpur 47500, Malaysia.
Marwan GhosnHematology and Oncology Department, Saint Joseph University, Beirut 1104 2020, Lebanon.
Philip PoortmansIridium Kankernetwerk and Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Wilrijk-Antwerp, Belgium.ORCID 0000-0001-7400-2293
Mohamed A ShehataClinical oncology Department, Menoufia University, Shebin Elkom 51132, Egypt.
Armando E GiulianoDepartment of Surgery, Surgical Oncology Division, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Jessica W T LeungDepartment of Breast Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Valentina GuarneriDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Istituto Oncologico Veneto IOV IRCCS, 35128 Padova, Italy.
Joseph GligorovInstitut Universitaire de Cancérologie AP-HP. Sorbonne Université, INSERM U938, 75013 Paris, France.
Bahadir M GulluogluBreast & Endocrine Surgery Unit, Marmara University School of Medicine, University Hospital, Istanbul 34722, Turkey.
Hany Abdel AzizClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.
Mona FrolovaFederal State Budgetary Institution "NN Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation, 127994 Moscow, Russia.
Mohamed SabryClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.
Charles M BalchSurgical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Roberto OrecchiaScientific Directorate, IRCCS European Institute of Oncology (IEO), and University of Milan, 20122 Milan, Italy.
Heba M El-ZawahryClinical Oncology Department, Kasr Alainy School of Medicine, Cairo University, Giza 12613, Egypt.
Sana Al-SukhunAl Hyatt Oncology Practice, Amman 11183, Jordan.ORCID 0000-0002-1641-7607
Khaled Abdel KarimClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.
Alaa KandilDepartment of Clinical Oncology, Alexandria School of Medicine, Alexandria 21131, Egypt.ORCID 0000-0001-7128-2971
Ruslan M PaltuevRussian Association of Oncological Mammology, Department of Breast Tumours of Federal State Budgetary Institution "Petrov Research Institute of Oncology", 197758 Saint Petersburg, Russia.
Meteb FoheidiCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Adult Medical Oncology, Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs-Western Region, Jeddah 22384, Saudi Arabia.
Mohamed El-ShinawiDepartment of General Surgery, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.ORCID 0000-0003-3645-2343
Manal ElMahdyDepartment of Pathology, Ain shams University, Cairo 11566, Egypt.
Omalkhair AbulkhairOncology Department, Alfaisal university, Alhabib Hospital, Riyad 11533, Saudi Arabia.ORCID 0000-0001-7107-8743
Wentao YangDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Adel T ArefThe School of Public Health, University of Adelaide, Adelaide 5005, Australia.
Joaira BakkachBiomedical Genomics & Oncogenetics Research Laboratory, Faculty of Sciences and Techniques of Tangier, Abdel Malek Essaadi University, Tangier 90000, Morocco.
Nermean Bahie EldinClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.
Hagar ElghazawyClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.ORCID 0000-0001-6839-4147
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
BRCA mutationsconsensusimmunotherapyplatinumtriple-negative breast cancer
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.